In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on AnaptysBio (ANAB – Research Report), with a price target ...

SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional ...

AnaptysBio (ANAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

“NOT GOOD” FOR BIOTECH SECTOR: RBC Capit AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the ...

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency ...

At close: 17 April at 16:00:01 GMT-4 ...

Good Logo vs Bad Logo Design and How it can Affect your Business. A logo that is eye-catching and unique is the only way to survive. Home > Logo Design > Good Logo vs Bad Logo Design & How it can ...

The biggest stories of the day delivered to your inbox.